BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 20712855)

  • 1. Downregulation of metastasis suppressor 1(MTSS1) is associated with nodal metastasis and poor outcome in Chinese patients with gastric cancer.
    Liu K; Wang G; Ding H; Chen Y; Yu G; Wang J
    BMC Cancer; 2010 Aug; 10():428. PubMed ID: 20712855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant SERCA3 expression is closely linked to pathogenesis, invasion, metastasis, and prognosis of gastric carcinomas.
    Xu XY; Gou WF; Yang X; Wang GL; Takahashi H; Yu M; Mao XY; Takano Y; Zheng HC
    Tumour Biol; 2012 Dec; 33(6):1845-54. PubMed ID: 22948776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
    Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
    Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer.
    Zhang Q; Ye Z; Yang Q; He X; Wang H; Zhao Z
    World J Surg Oncol; 2012 Jun; 10():103. PubMed ID: 22681645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastasis suppressor protein 1 regulated by PTEN suppresses invasion, migration, and EMT of gastric carcinoma by inactivating PI3K/AKT signaling.
    Wang H; Zhao Y; Cao L; Zhang J; Wang Y; Xu M
    J Cell Biochem; 2019 Mar; 120(3):3447-3454. PubMed ID: 30246429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serpin peptidase inhibitor clade A member 1 is a biomarker of poor prognosis in gastric cancer.
    Kwon CH; Park HJ; Lee JR; Kim HK; Jeon TY; Jo HJ; Kim DH; Kim GH; Park DY
    Br J Cancer; 2014 Nov; 111(10):1993-2002. PubMed ID: 25211665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and Significances of MTSS1 in Pancreatic Cancer.
    Zhou L; Li J; Shao QQ; Guo JC; Liang ZY; Zhou WX; Zhang TP; You L; Zhao YP
    Pathol Oncol Res; 2016 Jan; 22(1):7-14. PubMed ID: 26198729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low expression of SOCS-1 and SOCS-3 is a poor prognostic indicator for gastric cancer patients.
    Li G; Xu J; Wang Z; Yuan Y; Li Y; Cai S; He Y
    J Cancer Res Clin Oncol; 2015 Mar; 141(3):443-52. PubMed ID: 25261987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beclin 1 expression is an independent prognostic factor for gastric carcinomas.
    Yu M; Gou WF; Zhao S; Xiao LJ; Mao XY; Xing YN; Takahashi H; Takano Y; Zheng HC
    Tumour Biol; 2013 Apr; 34(2):1071-83. PubMed ID: 23334926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NEDD9 overexpression correlates with the progression and prognosis in gastric carcinoma.
    Shi R; Wang L; Wang T; Xu J; Wang F; Xu M
    Med Oncol; 2014 Mar; 31(3):852. PubMed ID: 24469954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic relevance of Tensin4 expression in human gastric cancer.
    Sakashita K; Mimori K; Tanaka F; Kamohara Y; Inoue H; Sawada T; Hirakawa K; Mori M
    Ann Surg Oncol; 2008 Sep; 15(9):2606-13. PubMed ID: 18612693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of PCDH9 is associated with the differentiation of tumor cells and metastasis and predicts poor survival in gastric cancer.
    Chen Y; Xiang H; Zhang Y; Wang J; Yu G
    Clin Exp Metastasis; 2015 Jun; 32(5):417-28. PubMed ID: 25869928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of Metastasis Suppressor-1, MTSS1, on oesophageal squamous cell carcinoma and its clinical significance.
    Xie F; Ye L; Chen J; Wu N; Zhang Z; Yang Y; Zhang L; Jiang WG
    J Transl Med; 2011 Jun; 9():95. PubMed ID: 21696600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased expression of RASSF6 is a novel independent prognostic marker of a worse outcome in gastric cancer patients after curative surgery.
    Wen Y; Wang Q; Zhou C; Yan D; Qiu G; Yang C; Tang H; Peng Z
    Ann Surg Oncol; 2011 Dec; 18(13):3858-67. PubMed ID: 21442347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrophosphatase overexpression is associated with cell migration, invasion, and poor prognosis in gastric cancer.
    Jeong SH; Ko GH; Cho YH; Lee YJ; Cho BI; Ha WS; Choi SK; Kim JW; Lee CW; Heo YS; Shin SH; Yoo J; Hong SC
    Tumour Biol; 2012 Dec; 33(6):1889-98. PubMed ID: 22797819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased levels of SLP-2 correlate with poor prognosis in gastric cancer.
    Liu D; Zhang L; Shen Z; Tan F; Hu Y; Yu J; Li G
    Gastric Cancer; 2013 Oct; 16(4):498-504. PubMed ID: 23371255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TPX2 expression is associated with poor survival in gastric cancer.
    Tomii C; Inokuchi M; Takagi Y; Ishikawa T; Otsuki S; Uetake H; Kojima K; Kawano T
    World J Surg Oncol; 2017 Jan; 15(1):14. PubMed ID: 28069036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of Grb2/HER2 signaling in Chinese gastric cancer: their relationship with clinicopathological parameters and prognostic significance.
    Yu GZ; Chen Y; Wang JJ
    J Cancer Res Clin Oncol; 2009 Oct; 135(10):1331-9. PubMed ID: 19337752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and clinical significance of miR-23a and metastasis suppressor 1 in colon carcinoma].
    Tang HL; Deng M; Liao QJ; Zeng X; Zhou XT; Su Q
    Zhonghua Bing Li Xue Za Zhi; 2012 Jan; 41(1):28-32. PubMed ID: 22455847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of miR-193b down-regulation and miR-196a up-regulation with clinicopathological features and prognosis in gastric cancer.
    Mu YP; Tang S; Sun WJ; Gao WM; Wang M; Su XL
    Asian Pac J Cancer Prev; 2014; 15(20):8893-900. PubMed ID: 25374225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.